PubRank
Search
About
R S Sloan
Author PubWeight™ 33.95
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Comparative nephrotoxicity of aminoglycoside antibiotics in rats.
J Infect Dis
1978
1.83
2
Multiple-dose ciprofloxacin kinetics in normal subjects.
Clin Pharmacol Ther
1984
1.62
3
Overnight urine collections to estimate sodium intake.
Hypertension
1983
1.58
4
Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake.
Hypertension
1983
1.19
5
Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure.
Antimicrob Agents Chemother
1977
1.18
6
Effects of vancomycin on renal function in rats.
Antimicrob Agents Chemother
1981
1.17
7
Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
Clin Pharmacol Ther
1983
1.16
8
Recovery from aminoglycoside nephrotoxicity with continued drug administration.
Antimicrob Agents Chemother
1978
1.12
9
Mezlocillin pharmacokinetics in renal impairment.
Clin Pharmacol Ther
1980
1.05
10
Intra- and interindividual variability in sodium intake in normal subjects and in patients with renal insufficiency.
Am J Kidney Dis
1986
1.04
11
Comparative nephrotoxicity of SCH 21420 and amikacin in rats.
Antimicrob Agents Chemother
1979
1.02
12
Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function.
J Infect Dis
1984
1.02
13
Moxalactam pharmacokinetics during hemodialysis.
Antimicrob Agents Chemother
1981
1.02
14
Tobramycin kinetics during continuous ambulatory peritoneal dialysis.
Clin Pharmacol Ther
1983
1.00
15
Nephrotoxicity of netilmicin in combination with non-aminoglycoside antibiotics.
Antimicrob Agents Chemother
1978
0.98
16
Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
Clin Pharmacol Ther
1983
0.96
17
Fluoxetine kinetics and protein binding in normal and impaired renal function.
Clin Pharmacol Ther
1984
0.95
18
The effect of piperacillin dose on elimination kinetics in renal impairment.
Eur J Clin Pharmacol
1983
0.94
19
Protection from gentamicin nephrotoxicity by cephalothin and carbenicillin.
Antimicrob Agents Chemother
1979
0.93
20
Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.
Antimicrob Agents Chemother
1978
0.92
21
Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans.
Hypertension
1985
0.91
22
The effect of dietary sodium and protein on urine volume and water intake.
J Lab Clin Med
1983
0.90
23
Mezlocillin dose dependent elimination kinetics in renal impairment.
Eur J Clin Pharmacol
1982
0.88
24
Nitrendipine kinetics in normal and impaired renal function.
Clin Pharmacol Ther
1985
0.83
25
Influence of home monitoring on compliance with a reduced sodium intake diet.
Arch Intern Med
1984
0.82
26
Pharmacokinetics of moxalactam in patients with normal and impaired renal function.
J Infect Dis
1982
0.81
27
The utility of overnight urine collections in assessing compliance with a low sodium intake diet.
JAMA
1983
0.81
28
Comparative low-dose nephrotoxicities of dibekacin, gentamicin, and tobramycin.
J Antimicrob Chemother
1982
0.79
29
Mezlocillin kinetics in hepatic insufficiency.
Clin Pharmacol Ther
1983
0.78
30
The treatment of anemia with low-dose recombinant human erythropoietin.
Am J Nephrol
1990
0.78
31
Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function.
Antimicrob Agents Chemother
1990
0.77
32
The efficacy of quantitative and qualitative chloride titrators in the estimation of human salt intake.
Klin Wochenschr
1985
0.77
33
The effect of chloride-containing potassium supplements on chloride titrator estimates of dietary sodium intake.
J Am Coll Nutr
1985
0.76
34
Short-term augmented calcium intake has no effect on sodium homeostasis.
Clin Pharmacol Ther
1986
0.75
35
Immune complex nephritis in nude mice.
Nephron
1981
0.75
36
Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients.
Am J Kidney Dis
1991
0.75
37
Nizatidine disposition in subjects with normal and impaired renal function.
Clin Pharmacol Ther
1988
0.75
38
Pharmacokinetics of cinoxacin in patients with renal failure.
J Antimicrob Chemother
1978
0.75
39
Achieving compliance to a reduced sodium diet.
Nurse Pract
1985
0.75
40
Determining specific gravity of urine with reagent sticks.
Clin Chem
1984
0.75
41
Population pharmacokinetics of the active metabolite of nabumetone in renal dysfunction.
Clin Pharmacol Ther
1995
0.75
42
Preventing sexual abuse of children: a model school education program.
J Community Health Nurs
1984
0.75